Literature DB >> 25647717

Safety surveillance of traditional Chinese medicine: current and future.

Shwu-Huey Liu1, Wu-Chang Chuang, Wing Lam, Zaoli Jiang, Yung-Chi Cheng.   

Abstract

Herbal medicine, including traditional Chinese medicine, has been used for the prevention, treatment, and cure of disorders or diseases for centuries. In addition to being used directly as therapeutic agents, medicinal plants are also important sources for pharmacological drug research and development. With the increasing consumption of herbal products intended to promote better health, it is extremely important to assure the safety and quality of herbal preparations. However, under current regulation surveillance, herbal preparations may not meet expectations in safety, quality, and efficacy. The challenge is how to assure the safety and quality of herbal products for consumers. It is the responsibility of producers to minimize hazardous contamination and additives during cultivation, harvesting, handling, processing, storage, and distribution. This article reviews the current safety obstacles that have been involved in traditional Chinese herbal medicine preparations with examples of popular herbs. Approaches to improve the safety of traditional Chinese medicine are proposed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25647717      PMCID: PMC4348117          DOI: 10.1007/s40264-014-0250-z

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  70 in total

1.  Liver enzyme elevations in patients treated with traditional Chinese medicine.

Authors:  D Melchart; K Linde; W Weidenhammer; S Hager; D Shaw; R Bauer
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

Review 2.  Chinese herbal medicine toxicology database: monograph on Herba Asari, "xi xin".

Authors:  Anna K Drew; Ian M Whyte; Alan Bensoussan; Andrew H Dawson; Xiaoshu Zhu; Stephen P Myers
Journal:  J Toxicol Clin Toxicol       Date:  2002

Review 3.  Toxicological risks of Chinese herbs.

Authors:  Debbie Shaw
Journal:  Planta Med       Date:  2010-11-12       Impact factor: 3.352

4.  Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy)

Authors:  L J Vanherweghem
Journal:  J Altern Complement Med       Date:  1998       Impact factor: 2.579

5.  Adverse reactions to drug additives.

Authors:  R A Simon
Journal:  J Allergy Clin Immunol       Date:  1984-10       Impact factor: 10.793

6.  Herbal composition PC-SPES for management of prostate cancer: identification of active principles.

Authors:  Milos Sovak; Allen L Seligson; Martin Konas; Marian Hajduch; Marek Dolezal; Miroslav Machala; Robert Nagourney
Journal:  J Natl Cancer Inst       Date:  2002-09-04       Impact factor: 13.506

7.  Lead poisoning caused by contaminated Cordyceps, a Chinese herbal medicine: two case reports.

Authors:  T N Wu; K C Yang; C M Wang; J S Lai; K N Ko; P Y Chang; S H Liou
Journal:  Sci Total Environ       Date:  1996-04-05       Impact factor: 7.963

8.  Complementary and alternative medicine use among general surgery, hepatobiliary surgery and surgical oncology patients.

Authors:  Colin Schieman; Luke R Rudmik; Elijah Dixon; Francis Sutherland; Oliver F Bathe
Journal:  Can J Surg       Date:  2009-10       Impact factor: 2.089

9.  Risk of liver injury associated with Chinese herbal products containing radix bupleuri in 639,779 patients with hepatitis B virus infection.

Authors:  Chang-Hsing Lee; Jung-Der Wang; Pau-Chung Chen
Journal:  PLoS One       Date:  2011-01-12       Impact factor: 3.240

10.  Ma-huang strikes again: ephedrine nephrolithiasis.

Authors:  T Powell; F F Hsu; J Turk; K Hruska
Journal:  Am J Kidney Dis       Date:  1998-07       Impact factor: 11.072

View more
  60 in total

Review 1.  Phototoxicity of traditional chinese medicine (TCM).

Authors:  Xiaoqi Li; Rui An; Kun Liang; Xinhong Wang; Lisha You
Journal:  Toxicol Res (Camb)       Date:  2018-08-27       Impact factor: 3.524

2.  Is there a role for botanical medicines in the twenty-first century?: Promotion of untested traditional therapies by the World Health Organization and China endangers global public health.

Authors:  Arthur P Grollman; Donald M Marcus
Journal:  EMBO Rep       Date:  2020-10-27       Impact factor: 8.807

3.  Including Traditional Chinese Medicine Diagnoses in ICD-11 May Not Advance the Evaluation of Traditional Chinese Medicine Therapies.

Authors:  Stewart Geary
Journal:  Pharmaceut Med       Date:  2019-10

Review 4.  Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs.

Authors:  Rolf Teschke; Dominique Larrey; Dieter Melchart; Gaby Danan
Journal:  Medicines (Basel)       Date:  2016-07-19

5.  The Haoqin-Huaban formula alleviates UVB-induced skin damage through HOXA11-AS-mediated stabilization of EZH2.

Authors:  Xuying Xu; Siyi Wang; Dongmei Zhou; Jianhua Qu; Cang Zhang; Yichuan Xu; Liyun Sun
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 4.060

6.  Hotspot Analysis of Traditional Drugs in Diabetes Treatment Literature.

Authors:  Hui Shen; Wei-Kai Zhu; Zhi Lu; Hai-Cheng Zhou
Journal:  Chin J Integr Med       Date:  2020-09-30       Impact factor: 1.978

Review 7.  Nephrotoxicity and Chinese Herbal Medicine.

Authors:  Bo Yang; Yun Xie; Maojuan Guo; Mitchell H Rosner; Hongtao Yang; Claudio Ronco
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-03       Impact factor: 8.237

8.  Adverse drug reactions of Yunnan Baiyao capsule: a multi-center intensive monitoring study in China.

Authors:  Bo Li; Shuo Feng; Zhi-Hong Wu; Joey S W Kwong; Jing Hu; Nan Wu; Gui-Hua Tian; Hong-Cai Shang; Gui-Xing Qiu
Journal:  Ann Transl Med       Date:  2019-03

9.  A real-world study on adverse drug reactions to Xuebijing injection: hospital intensive monitoring based on 93 hospitals (31,913 cases).

Authors:  Rui Zheng; Hui Wang; Zhi Liu; Xiaohui Wang; Jing Li; Xiang Lei; Yilin Fan; Si Liu; Zhiqiao Feng; Hongcai Shang
Journal:  Ann Transl Med       Date:  2019-03

10.  Early life stage transient aristolochic acid exposure induces behavioral hyperactivity but not nephrotoxicity in larval zebrafish.

Authors:  Jiangfei Chen; Aijun Kong; Delia Shelton; Haojia Dong; Jiani Li; Fan Zhao; Chenglian Bai; Kaiyu Huang; Wen Mo; Shan Chen; Hui Xu; Robyn L Tanguay; Qiaoxiang Dong
Journal:  Aquat Toxicol       Date:  2021-07-18       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.